The Impact of RSV Hospitalization on Children’s Quality of Life
Open Access
Abstract
Background: Respiratory syncytial virus (RSV) is one of the most frequent etiological factors of lower respiratory tract infections in children, potentially affecting patients’ quality of life (QoL). We aimed to asses QoL in children under 2 years of age hospitalized due to laboratory-confirmed RSV infection. Methods: A QoL was assessed by parents/tutors with the use of the 100-point visual analog scale and compared against a disease-free period. We evaluated the median utility, QoL loss (reported in days), and quality-adjusted life years (QALY) loss in relation to RSV hospitalization. Results: We included 132 patients aged from 17 days to 24 months (median 3.8 months). The mean utility during the hospitalization varied between 0.418 and 0.952, with a median of 0.679 (95%CI: 0.6–0.757) and median loss of 0.321 [0.243–0.4], which further translated into a loss of 2.2 days (95%CI: 1.6–3.1). The QALY loss varied between 0.526 × 10−3 and 24.658 × 10−3, with a median of 6.03 × 10−3 (95%CI: 4.38–8.48 × 10−3). Based upon the final diagnoses, the highest QALY loss was 6.99 × 10−3 (95%CI: 5.29–13.7 × 10−3) for pneumonia, followed by bronchiolitis—5.96 × 10−3 (4.25–8.41 × 10−3) and bronchitis—4.92 × 10−3 (2.93–6.03 × 10−3); significant differences were observed only between bronchitis and pneumonia (p = 0.0171); the QALY loss was not age-dependent. Although an increasing tendency in the utility score was observed, a strong cumulative effect related to the length of stay was noted until day 13. Conclusions: RSV contributes significantly to the utility deterioration and QALY loss in the case of RSV hospitalization, and the patient-reported data should be used in pharmacoeconomic assessments of the impact of RSV.Keywords
Funding Information
- CMKP (501-1-020-19-23)
This publication has 29 references indexed in Scilit:
- Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countriesExpert Review of Anti-infective Therapy, 2020
- Systematic review on respiratory syncytial virus epidemiology in adults and the elderly in Latin AmericaInternational Journal of Infectious Diseases, 2020
- Estimated Burden of Community-Onset Respiratory Syncytial Virus–Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014–15Journal of the Pediatric Infectious Diseases Society, 2019
- Estimates for quality of life loss due to Respiratory Syncytial VirusInfluenza and Other Respiratory Viruses, 2019
- Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm InfantsClinical Pediatrics, 2019
- Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatmentsAllergy, 2018
- A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II: Evaluation of Psychometric Performance of English-Language Versions in a General PopulationValue in Health, 2015
- A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I: Descriptive CharacteristicsValue in Health, 2015
- Calidad de vida en lactantes nacidos prematuros según ingresos por infección respiratoriaAnales de Pediatría, 2010
- The Impact of Severe Respiratory Syncytial Virus on the Child, Caregiver, and Family During Hospitalization and RecoveryPediatrics, 2005